Microsatellite Analysis of Early Stage (Ia-IIb) Uterine Cervical Squamous Carcinoma

International Journal of Surgical Pathology

Volumn 11, Issue 4, 2003, Pages 253-260

  Clarke, B ^a   Gordon, M ^a   Moodley, M ^a   Naidoo, R ^a   Chetty, R ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Cervix; Loss of heterozygosity; Microsatellite instability

Indexed keywords

APC PROTEIN; MICROSATELLITE DNA; ONCOPROTEIN; PROTEIN; PROTEIN MLH1; PROTEIN MLH2; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CHROMOSOME 3; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HETEROZYGOSITY LOSS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; ONCOGENE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

EID: 0242552705     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690301100402     Document Type: Article

References (25)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19, 1999
2. Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol 82:238-246, 2001
3. Naidoo R, Chetty R. The application of microsatellites in molecular pathology. Pathol Oncol Res 4:310-315, 1998
4. Helland A, Borresen-Dale AL, Peltomaki P, Hektoen M, Kristensen GB, Nesland JM, de la CA, Lothe RA. Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 70:499-501, 1997
5. Chetty R, Pulford K, Jones M, Mathieu-Mahul D, Close P, Hussein S, Pallesen G, Ralfkiaer E, Stein H, Gatter K. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: An immunohistochemical and genotypic study. Hum Pathol 26:994-998, 1995
6. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56:3331-3337, 1996
7. Kornberg A. The golden helix. University Science Books, California, 1995
8. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer 80:2008-2018, 1999
9. Chung TK, Cheung TH, Wang VW, Yu MY, Wong YF. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association. Gynecol Obstet Invest 52:98-103, 2001
10. Clarke B, Chetty R. Postmodern cancer: The role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 55:19-24, 2002
11. Wistuba II, Syed S, Behrens C, Duong M, Milchgrub S, Muller CY, Jagirdar J, Gazdar AF. Comparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects. Gynecol Oncol 74:519-526, 1999
12. Butler D, Collins C, Mabruk M, Leader MB, Kay EW. Loss of FHIT expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Gynecol Oncol 86:144-149, 2002
13. Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA. Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1, and TP53 in relation to survival. Int J Cancer 88:217-222, 2000
14. Fouret PJ, Dabit D, Mergui JL, Uzan S. Loss of heterozygosity on the short arm of chromosome 3 in cervical intra-epithelial neoplasia without concomitant cervical carcinoma. Pathobiology 66:306-310, 1998
15. Chung TK, Cheung TH, Lo WK, Yu MY, Hampton GM, Wong HK, Wong YF. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intreaepithelial neoplasia. Cancer Lett 154:189-194, 2000
16. Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, Hirohashi S, Vissing H, Shimizu M, Oshimura M. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 8:1825-1832, 1993
17. Kersemaekers AM, van de Vijver MJ, Kenter GG, Fleuren GJ. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Genes Chromosomes Cancer 26:346-354, 1999
18. Kersemaekers AM, Hermans J, Fleuren GJ, van de Vijver MJ. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer 77:192-200, 1998
19. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP. Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 56:197-205, 1996
20. Luft F, Gebert J, Schneider A, Melsheimer P, von Knebel DM. Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. Int J Gynecol Pathol 18:374-380, 1999
21. Carey TE, Frank CJ, Raval JR, Jones JW, McClatchey KD, Beals TF, Worsham MJ, Van Dyke DL. Identifying genetic changes associated with tumor progression in squamous cell carcinoma. Acta Otolaryngol 529(Suppl):229-232, 1997
22. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 54:4481-4487, 1994
23. Larson AA, Kern S, Sommers RL, Yokota J, Cavenee WK, Hampton GM. Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Res 56:1426-1431, 1996
24. Hu X, Guo Z, Pang T, Li Q, Afink G, Ponten J. Immunohistochemical and DNA sequencing analysis on human mismatch repair gene MLH1 in cervical squamous cell carcinoma with LOH of this gene. Anticancer Res 20:171-175, 2000
25. Nishimura M, Furumoto H, Kato T, Kamada M, Aono T. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer. Gynecol Oncol 79:201-206, 2000